Population Pharmacokinetics of Peramivir in Healthy Volunteers and Influenza Patients

Documenti analoghi

• Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection
  di: Sugaya, Norio, et al.
  Pubblicazione: (2012)
• 1536. Population Pharmacokinetic Analysis of Baloxavir Morboxil, a Cap-Dependent Endonuclease Inhibitor, in Adult and Adolescent Healthy Subjects and Influenza Patients and Exposure-Response Relationships in the Patients at High-Risk of Influenza Complications
  di: Koshimichi, Hiroki, et al.
  Pubblicazione: (2019)
• Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Influenza Patients at High Risk of Complications
  di: Koshimichi, Hiroki, et al.
  Pubblicazione: (2020)
• Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
  di: Koshimichi, Hiroki, et al.
  Pubblicazione: (2018)
• Effect of Fosamprenavir-Ritonavir on the Pharmacokinetics of Dolutegravir in Healthy Subjects
  di: Song, Ivy, et al.
  Pubblicazione: (2014)